Consensus of the International Interdisciplinary Expert Council on the treatment of comorbidities in pediatric ADHD
Authors:
- V.P. ZykovVZV.P. Zykov
- O.V. BykovaOBO.V. Bykova
- N.A. GeppeNGN.A. Geppe
- A.V. GoryunovAGA.V. Goryunov
- A.V. GoryunovaAGA.V. Goryunova
- N.A. ErmolenkoNEN.A. Ermolenko
- I.N. ZakharovaIZI.N. Zakharova
- S.K. ZyryanovSZS.K. Zyryanov
- E.V. KasanaveEKE.V. Kasanave
- O.V. KalyuzhinOKO.V. Kalyuzhin
- O.L. LapochkinOLO.L. Lapochkin
- 14 May 2026
- journal article
- consensus statement
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (4) , 129-134
Abstract
On March 19, 2026, in Moscow, an international interdisciplinary Expert Council convened during the III National Congress of Pediatric Neurologists to address the treatment of comorbid conditions associated with ADHD in children. It was observed that comorbid disorders, such as anxiety, sleep disturbances, and heightened nervous excitability, affect at least 70% of patients, exacerbating clinical symptoms of ADHD and diminishing treatment efficacy. The experts evaluated the evidence supporting the use of multicomponent low-dose formulations derived from plant extracts and minerals, specifically Nervoheel (for children aged 3 years and older) and Neurexan (for those aged 12 years and older). These formulations are approved in the Russian Federation as medical products and have demonstrated effectiveness in alleviating neurotic manifestations, anxiety, and sleep disorders, as well as improving focus and compliance. Following the Expert Council’s statement, these medications received a favorable evaluation regarding their effectiveness in managing anxiety, sleep disorders, and nervous. They were recommended for inclusion in the Ministry of Health of the Russian Federation’s clinical guidelines, with a strength of recommendation of C and a quality of evidence rating of 3.Keywords
This publication has 16 references indexed in Scilit:
- The Relationship Between Speech and Language Disorders and Working Memory: Children with Attention Deficit and Hyperactivity Disorder and Typical DevelopmentJournal of Attention Disorders, 2023
- EEG revealed improved vigilance regulation after stress exposure under Nx4 - A randomized, placebo-controlled, double-blind, cross-over trialIBRO Neuroscience Reports, 2021
- Executive Functioning Heterogeneity in Pediatric ADHDJournal of Abnormal Child Psychology, 2018
- International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity DisorderEuropean Addiction Research, 2018
- Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormonesHormones and Behavior, 2015
- Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and LatiumEpidemiology and Psychiatric Sciences, 2014
- Effectiveness of the Homeopathic Preparation Neurexan®Compared with that of Commonly used Valerian-Based Preparations for the Treatment of Nervousness/Restlessness – an Observational StudyThe Scientific World Journal, 2009
- The Homeopathic Preparation Neurexan® vs. Valerian for the Treatment of Insomnia: An Observational StudyThe Scientific World Journal, 2008
- How effective are treatments for child and adolescent depression?Clinical Psychology Review, 2002
- The Homeopathic Preparation Nervoheel N Can Offer an Alternative to Lorazepam Therapy for Mild Nervous DisordersEvidence-Based Complementary and Alternative Medicine, 2000